Annual Operating Profit
-$254.45 M
-$120.15 M-89.46%
December 31, 2023
Summary
- As of February 23, 2025, VRDN annual operating income is -$254.45 million, with the most recent change of -$120.15 million (-89.46%) on December 31, 2023.
- During the last 3 years, VRDN annual operating profit has fallen by -$213.93 million (-527.98%).
- VRDN annual operating profit is now -56823.94% below its all-time high of -$447.00 thousand, reached on December 31, 2013.
Performance
VRDN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$83.48 M
-$11.29 M-15.64%
September 30, 2024
Summary
- As of February 23, 2025, VRDN quarterly operating income is -$83.48 million, with the most recent change of -$11.29 million (-15.64%) on September 30, 2024.
- Over the past year, VRDN quarterly operating profit has dropped by -$32.26 million (-62.97%).
- VRDN quarterly operating profit is now -1941495.35% below its all-time high of $4300.00, reached on December 31, 2013.
Performance
VRDN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$283.04 M
-$32.26 M-12.86%
September 30, 2024
Summary
- As of February 23, 2025, VRDN TTM operating income is -$283.04 million, with the most recent change of -$32.26 million (-12.86%) on September 30, 2024.
- Over the past year, VRDN TTM operating profit has dropped by -$51.00 million (-21.98%).
- VRDN TTM operating profit is now -356825.60% below its all-time high of -$79.30 thousand, reached on March 31, 2013.
Performance
VRDN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
VRDN Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.5% | -63.0% | -22.0% |
| 3 y3 years | -528.0% | -63.0% | -22.0% |
| 5 y5 years | -669.1% | -63.0% | -22.0% |
VRDN Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -219.2% | at low | -222.4% | at low | -255.0% | at low |
| 5 y | 5-year | -528.0% | at low | -1443.1% | at low | -848.1% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
Viridian Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$83.48 M(+15.6%) | -$283.04 M(+12.9%) |
| Jun 2024 | - | -$72.19 M(+29.1%) | -$250.79 M(+5.4%) |
| Mar 2024 | - | -$55.90 M(-21.8%) | -$237.87 M(-6.5%) |
| Dec 2023 | -$254.45 M(+89.5%) | -$71.48 M(+39.5%) | -$254.45 M(+9.7%) |
| Sep 2023 | - | -$51.22 M(-13.6%) | -$232.04 M(+10.2%) |
| Jun 2023 | - | -$59.27 M(-18.2%) | -$210.60 M(+16.4%) |
| Mar 2023 | - | -$72.47 M(+47.7%) | -$180.89 M(+34.7%) |
| Dec 2022 | -$134.30 M(+68.5%) | -$49.07 M(+64.7%) | -$134.30 M(+17.5%) |
| Sep 2022 | - | -$29.79 M(+0.7%) | -$114.32 M(+15.9%) |
| Jun 2022 | - | -$29.56 M(+14.2%) | -$98.67 M(+13.3%) |
| Mar 2022 | - | -$25.89 M(-11.0%) | -$87.10 M(+9.2%) |
| Dec 2021 | -$79.73 M(+96.8%) | -$29.08 M(+105.8%) | -$79.73 M(+11.7%) |
| Sep 2021 | - | -$14.13 M(-21.5%) | -$71.38 M(+13.9%) |
| Jun 2021 | - | -$18.00 M(-2.8%) | -$62.66 M(+22.8%) |
| Mar 2021 | - | -$18.52 M(-10.7%) | -$51.04 M(+26.0%) |
| Dec 2020 | -$40.52 M(-3.5%) | -$20.74 M(+283.3%) | -$40.52 M(+35.7%) |
| Sep 2020 | - | -$5.41 M(-15.1%) | -$29.85 M(-16.3%) |
| Jun 2020 | - | -$6.37 M(-20.3%) | -$35.67 M(-6.7%) |
| Mar 2020 | - | -$8.00 M(-20.6%) | -$38.24 M(-8.9%) |
| Dec 2019 | -$41.98 M(+26.9%) | -$10.07 M(-10.3%) | -$41.98 M(-0.9%) |
| Sep 2019 | - | -$11.23 M(+25.6%) | -$42.36 M(+5.2%) |
| Jun 2019 | - | -$8.94 M(-23.8%) | -$40.28 M(+0.2%) |
| Mar 2019 | - | -$11.74 M(+12.3%) | -$40.20 M(+21.5%) |
| Dec 2018 | -$33.08 M | -$10.45 M(+14.2%) | -$33.08 M(+14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$9.15 M(+3.3%) | -$28.98 M(+12.7%) |
| Jun 2018 | - | -$8.86 M(+91.8%) | -$25.72 M(+6.2%) |
| Mar 2018 | - | -$4.62 M(-27.3%) | -$24.21 M(-8.7%) |
| Dec 2017 | -$26.53 M(+174.3%) | -$6.35 M(+7.9%) | -$26.53 M(+16.3%) |
| Sep 2017 | - | -$5.89 M(-19.9%) | -$22.82 M(+21.7%) |
| Jun 2017 | - | -$7.35 M(+5.9%) | -$18.74 M(+35.1%) |
| Mar 2017 | - | -$6.94 M(+162.9%) | -$13.88 M(+43.5%) |
| Dec 2016 | -$9.67 M(-13.5%) | -$2.64 M(+45.3%) | -$9.67 M(-3.2%) |
| Sep 2016 | - | -$1.82 M(-26.9%) | -$9.99 M(-11.6%) |
| Jun 2016 | - | -$2.48 M(-9.2%) | -$11.30 M(-0.1%) |
| Mar 2016 | - | -$2.73 M(-7.5%) | -$11.31 M(+1.1%) |
| Dec 2015 | -$11.19 M(+60.6%) | -$2.96 M(-5.5%) | -$11.19 M(+5.7%) |
| Sep 2015 | - | -$3.13 M(+25.6%) | -$10.59 M(+16.4%) |
| Jun 2015 | - | -$2.49 M(-4.7%) | -$9.09 M(-3.4%) |
| Mar 2015 | - | -$2.61 M(+10.9%) | -$9.41 M(+35.1%) |
| Dec 2014 | -$6.97 M(+1458.6%) | -$2.36 M(+44.3%) | -$6.97 M(+51.2%) |
| Sep 2014 | - | -$1.63 M(-41.9%) | -$4.61 M(+40.2%) |
| Jun 2014 | - | -$2.81 M(+1583.2%) | -$3.29 M(+514.3%) |
| Mar 2014 | - | -$167.00 K(-3983.7%) | -$534.80 K(+19.6%) |
| Dec 2013 | -$447.00 K(-85.6%) | $4300.00(-101.4%) | -$447.10 K(-1.0%) |
| Sep 2013 | - | -$311.70 K(+416.1%) | -$451.40 K(+223.1%) |
| Jun 2013 | - | -$60.40 K(-23.8%) | -$139.70 K(+76.2%) |
| Mar 2013 | - | -$79.30 K | -$79.30 K |
| Dec 2012 | -$3.09 M | - | - |
FAQ
- What is Viridian Therapeutics annual operating income?
- What is the all time high annual operating profit for Viridian Therapeutics?
- What is Viridian Therapeutics annual operating profit year-on-year change?
- What is Viridian Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly operating profit year-on-year change?
- What is Viridian Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Viridian Therapeutics?
- What is Viridian Therapeutics TTM operating profit year-on-year change?
What is Viridian Therapeutics annual operating income?
The current annual operating profit of VRDN is -$254.45 M
What is the all time high annual operating profit for Viridian Therapeutics?
Viridian Therapeutics all-time high annual operating income is -$447.00 K
What is Viridian Therapeutics annual operating profit year-on-year change?
Over the past year, VRDN annual operating income has changed by -$120.15 M (-89.46%)
What is Viridian Therapeutics quarterly operating income?
The current quarterly operating profit of VRDN is -$83.48 M
What is the all time high quarterly operating profit for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly operating income is $4300.00
What is Viridian Therapeutics quarterly operating profit year-on-year change?
Over the past year, VRDN quarterly operating income has changed by -$32.26 M (-62.97%)
What is Viridian Therapeutics TTM operating income?
The current TTM operating profit of VRDN is -$283.04 M
What is the all time high TTM operating profit for Viridian Therapeutics?
Viridian Therapeutics all-time high TTM operating income is -$79.30 K
What is Viridian Therapeutics TTM operating profit year-on-year change?
Over the past year, VRDN TTM operating income has changed by -$51.00 M (-21.98%)